Showing results (31-40 of 703) with videos related to
Sort By:
Pageof 71
Cancer Chemotherapy and Pharmacology|February 28, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primatesE Fox, R F Murphy, C L McCully, et al.Cancer Research|August 1, 1988
Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primatesR L Heideman, F M Balis, C McCully, et al.Cancer|September 1, 1994
Acute pancreatitis after ifosfamide therapyS Izraeli, P C Adamson, S M Blaney, et al.Investigational New Drugs|May 1, 1993
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primateR L Heideman, C McCully, F M Balis, et al.Pharmaceutical Research|July 10, 2001
Probe calibration in transient microdialysis in vivoP M Bungay, R L Dedrick, E Fox, et al.Investigational New Drugs|November 1, 1993
Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkeyS L Berg, F M Balis, K S Godwin, et al.Cancer Drug Delivery|January 1, 1986
The influence of route of administration on the hepatic uptake of methotrexateF M Balis, R F Murphy, C M Lester, et al.Antimicrobial Agents and Chemotherapy|August 1, 1994
Quantitative relationships between zidovudine exposure and efficacy and toxicityG L Drusano, F M Balis, S R Gitterman, et al.Cancer Chemotherapy and Pharmacology|October 11, 2001
Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primatesW Salzer, B Widemann, C McCully, et al.Journal of Chromatography|March 16, 1990
High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluidsM E Carpen, D G Poplack, P A Pizzo, et al.Pageof 71